Preserving the intellectual output & resources of the University of Missouri.
Is your patient still using rosiglitazone?
MOspace/Manakin Repository
Breadcrumbs Navigation
Is your patient still using rosiglitazone?
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/10727
| Title: | Is your patient still using rosiglitazone? |
| Author: | Gov-Ari, Hanna K.; Stevermer, James J. |
| Keywords: |
type 2 diabetes
myocardial infarction cardiovascular mortality side effects |
| Date: | 2011-05 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | Journal of Family Practice, 60(5) 2011: 282-284. |
| Abstract: | Do not initiate rosiglitazone therapy for patients with diabetes, and consider switching those who are already taking it to pioglitazone. Strength of recommendation A: Based on a meta-analysis of 56 randomized trials. |
| URI: | http://hdl.handle.net/10355/10727 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Priority Updates to Research Literature (PURLs) [87]
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.